Second-generation drug-eluting stents in the elderly patients with acute coronary syndrome: the in-hospital and 12-month follow-up of the all-comer registry

被引:2
|
作者
Wanha, Wojciech [1 ]
Kawecki, Damian [2 ]
Roleder, Tomasz [1 ]
Morawiec, Beata [2 ]
Gladysz, Sylwia [1 ]
Kowalowka, Adam [3 ]
Jadczyk, Tomasz [1 ]
Adamus, Barbara [4 ]
Pawlowski, Tomasz [1 ]
Smolka, Grzegorz [1 ]
Kazmierski, Maciej [1 ]
Ochala, Andrzej [1 ]
Nowalany-Kozielska, Ewa [2 ]
Wojakowski, Wojciech [1 ]
机构
[1] Med Univ Silesia, Div Cardiol 3, Katowice, Poland
[2] Med Univ Silesia, Div Cardiol 2, Zabrze, Poland
[3] Med Univ Silesia, Div Cardiothorac Surg, Katowice, Poland
[4] Specialist Hosp, Div Cardiol, Wilkowice, Poland
关键词
Percutaneous coronary intervention; Drug-eluting stents; Elderly patients; ELEVATION MYOCARDIAL-INFARCTION; ANGIOPLASTY REGISTRY; CLINICAL-OUTCOMES; AGE; INTERVENTION; IMPACT; TRIALS; REVASCULARIZATION; ANTIPLATELET; ANGIOGRAPHY;
D O I
10.1007/s40520-016-0649-8
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Katowice-Zabrze registry provides data that can be used to evaluate clinical outcomes of percutaneous coronary interventions in elderly patients (>= 70 y/o) treated with either first- (DES-I) or second-generation (DES-II) drug-eluting stents (DES). Methods The registry consisted of data from 1916 patients treated with coronary interventions using either DES-I or DES-II stents. For our study, we defined patients >= 70 years of age as elderly. We evaluated any major adverse cardiac and cerebral events (MACCE) at 12-month follow-up. Results Coronary angiography revealed a higher incidence of multivessel coronary artery disease in this elderly patient population. There were no differences in acute and subacute stent thrombosis (0.4 vs. 0.6%, p = 0.760; 0.4 vs. 0.4%; p = 0.712). Elderly patients experienced more in-hospital bleeding complications requiring blood transfusion (2.0 vs. 0.9%; p = 0.003). Resuscitated cardiac arrests (2.0 vs. 0.9%; p = 0.084) were observed more often in this elderly patients during hospitalization. The composite in-hospital MACCE rates did not differ statistically between both groups (1.4 vs. 1.1%; p = 0.567). Data from a twelve-month follow-up disclosed that mortality was higher (7.1 vs. 1.8%; p < 0.001) in the elderly, with no difference in TVR (7.2 vs. 9.9%, p = 0.075), MI (6.0 vs. 4.8%, p = 0.300), stroke (0.8 vs. 0.6%, p = 0.600) and composite MACCE (15.0 vs. 13.4%, p = 0.324). The age of 70 years or over was an independent predictor of death [HR = 2.55 (95% CI 1.49-4.37); p < 0.001]. The use of DES-II reduced the risk of MI [HR = 0.40 (95% CI 0.19-0.82); p = 0.012] in the elderly. Conclusion This elderly patient population had an increased risk of in-hospital bleeding complications requiring blood transfusion and a higher risk of death at 12-month follow-up. The use of new-generation DES reduced the risk of MI in the elderly population.
引用
收藏
页码:885 / 893
页数:9
相关论文
共 50 条
  • [41] First-Generation Versus Second-Generation Drug-Eluting Stents in Coronary Chronic Total Occlusions: Two-Year Results of a Multicenter Registry
    Ahn, Jong-Hwa
    Yang, Jeong Hoon
    Yu, Cheol Woong
    Kim, Je Sang
    Lee, Hyun Jong
    Choi, Rak Kyeong
    Kim, Tae Hoon
    Jang, Ho Joon
    Choi, Young Jin
    Roh, Young Moo
    Shim, Won-Heum
    Bin Song, Young
    Hahn, Joo-Yong
    Choi, Jin-Ho
    Lee, Sang Hoon
    Gwon, Hyeon-Cheol
    Choi, Seung-Hyuk
    PLOS ONE, 2016, 11 (06):
  • [42] Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
    Stenestrand, Ulf
    James, Stefan K.
    Lindback, Johan
    Frobert, Ole
    Carlsson, Jorg
    Schersten, Fredrik
    Nilsson, Tage
    Lagerqvist, Bo
    EUROPEAN HEART JOURNAL, 2010, 31 (02) : 177 - 186
  • [43] Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents
    Harada, Yukinori
    Michel, Jonathan
    Lohaus, Raphaela
    Mayers, Katharina
    Emmer, Roberto
    Lahmann, Anna Lena
    Colleran, Roisin
    Giacoppo, Daniele
    Wolk, Annabelle
    ten Berg, Jurrien M.
    Neumann, Franz-Josef
    Hans, Yaling
    Adriaenssens, Tom
    Toelg, Ralph
    Seyfarth, Melchior
    Maeng, Michael
    Zrenner, Bernhard
    Jacobshagen, Claudius
    Wohrle, Jochen
    Kufner, Sebastian
    Morath, Tanja
    Ibrahim, Tareq
    Bernlochner, Isabel
    Fischer, Marcus
    Schunkert, Heribert
    Laugwitz, Karl-Ludwig
    Mehilli, Julinda
    Byrnes, Robert A.
    Kastrati, Adnan
    Schulz-Schuepke, Stefanie
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (10) : 1989 - 1999
  • [44] Five-year major clinical outcomes between first-generation and second-generation drug-eluting stents in acute myocardial infarction patients underwent percutaneous coronary intervention
    Kim, Yong Hoon
    Her, Ae-Young
    Rha, Seung-Woon
    Choi, Byoung Geol
    Choi, Se Yeon
    Byun, Jae Kyeong
    Baek, Ju Yeol
    Choi, Woong Gil
    Kang, Tae Soo
    Ahn, Ji Hoon
    Park, Sang-Ho
    Mashaly, Ahmed
    Na, Jin Oh
    Choi, Cheol Ung
    Lim, Hong Euy
    Kim, Eung Ju
    Park, Chang Gyu
    Seo, Hong Seog
    Oh, Dong Joo
    JOURNAL OF GERIATRIC CARDIOLOGY, 2018, 15 (08) : 523 - 533
  • [45] Second-Generation vs. First-Generation Drug-Eluting Stents in Patients With Calcified Coronary Lesions - Pooled Analysis From the RESET and NEXT Trials
    Nishida, Koji
    Nakatsuma, Kenji
    Shiomi, Hiroki
    Natsuaki, Masahiro
    Kawai, Kazuya
    Morimoto, Takeshi
    Kozuma, Ken
    Igarashi, Keiichi
    Kadota, Kazushige
    Tanabe, Kengo
    Morino, Yoshihiro
    Hibi, Kiyoshi
    Akasaka, Takashi
    Abe, Mitsuru
    Suwa, Satoru
    Muramatsu, Toshiya
    Kobayashi, Masakazu
    Dai, Kazuoki
    Nakao, Koichi
    Tarutani, Yasuhiro
    Fujii, Kenshi
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2018, 82 (02) : 376 - +
  • [46] Second-generation versus First generation Drug-eluting Stents in Patients With Calcified Coronary Lesions: Pooled Analysis From the RESET and NEXT Trials
    Nishida, Koji
    Nakatsuma, Kenji
    Shiomi, Hiroki
    Kawai, Kazuya
    Hamashige, Naohisa
    Morimoto, Takeshi
    Kimura, Takeshi
    CIRCULATION, 2014, 130
  • [47] Biodegradable polymer versus second-generation durable polymer drug-eluting stents in patients with coronary artery disease: A meta-analysis
    Wu, James J.
    Way, Joshua A. H.
    Roy, Probal
    Yong, Andy
    Lowe, Harry
    Kritharides, Leonard
    Brieger, David
    HEALTH SCIENCE REPORTS, 2018, 1 (11)
  • [48] Sustained risk of stent thrombosis and restenosis in first generation drug-eluting Stents after One Decade of Follow-up: A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
    Volz, Sebastian
    Angeras, Oskar
    Odenstedt, Jacob
    Ioanes, Dan
    Haraldsson, Inger
    Dworeck, Christian
    Redfors, Bjoern
    Ramunddal, Truls
    Albertsson, Per
    Petursson, Petur
    Omerovic, Elmir
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (06) : E403 - E409
  • [49] Clinical outcomes of first-and second-generation drug-eluting stents in patients undergoing rotational atherectomy for heavily calcified coronary lesions
    Tian, Wenjie
    Mahmoudi, Michael
    Lhermusier, Thibault
    Pendyala, Lakshmana K.
    Kiramijyan, Sarkis
    Saar, Minha
    Ota, Hideaki
    Chen, Fang
    Torguson, Rebecca
    Suddath, William O.
    Satler, Lowell F.
    Pichard, Augusto D.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2015, 16 (03) : 147 - 150
  • [50] Ten-year Outcomes After Drug-Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow-Up Study
    Jeong, Yeong Jin
    Ahn, Jung-Min
    Hyun, Junho
    Lee, Junghoon
    Kim, Ju Hyeon
    Yang, Yujin
    Choe, Kyungjin
    Park, Hanbit
    Kang, Do-Yoon
    Lee, Pil Hyung
    Kang, Soo-Jin
    Lee, Seung-Whan
    Kim, Young-Hak
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    Park, Duk-Woo
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (14):